David R Rosi, MD | |
715 W North Ave, Melrose Park, IL 60160-1612 | |
(708) 327-1518 | |
(708) 327-1501 |
Full Name | David R Rosi |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 715 W North Ave, Melrose Park, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104815596 | NPI | - | NPPES |
036054018 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RX0202X | Internal Medicine - Medical Oncology | 036054018 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
David R Rosi, MD 25068 Network Pl, Chicago, IL 60673-0001 Ph: (847) 585-7000 | David R Rosi, MD 715 W North Ave, Melrose Park, IL 60160-1612 Ph: (708) 327-1518 |
News Archive
So House Republicans have passed and sent to the Senate a budget that includes no funding for the Affordable Care Act, setting up a political showdown that could result in a government shutdown. We wish the GOP luck, since we support the policy if not the strategy. But however this charge into the fixed bayonets turns out, we hope the folks who planned it will take responsibility for what happens now (9/23).
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
› Verified 1 days ago
Dr. Samreen Mattoo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 W Lake St, Melrose Park, IL 60160 Phone: 708-938-7350 | |
Constantine G Delis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Superior St, Suite 203, Melrose Park, IL 60160 Phone: 708-338-1780 Fax: 708-338-1790 | |
Anupa Rai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Superior St, Suite 101, Melrose Park, IL 60160 Phone: 708-344-2161 | |
Dr. Peyman Pahlavan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 N. Broadway Avenue, Melrose Park, IL 60160 Phone: 708-345-8960 Fax: 708-345-8965 | |
Dr. Rachel Elizabeth Burt Kadar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 675 W North Ave Ste 505, Melrose Park, IL 60160 Phone: 708-450-4557 Fax: 708-338-0200 | |
Dr. Vijay Yeldandi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Superior St, 5th Floor, Melrose Park, IL 60160 Phone: 773-205-4661 Fax: 708-938-7098 |